Biovaluation Advisors

biovaluation advisors is a research-driven boutique advisory firm specialized in asset valuation in the life sciences industry. the company offers independent market and industry research, and provides financial and strategic advice for licensing, deal structuring, project- and firm valuations, r&d; strategy, investment strategies, merger and acquisitions, and venture fundraisings. biovaluation advisors bring new perspectives to the research frontiers. we regularly publish in academic and industry journals on topics such as valuation, licensing, corporate finance, mergers and acquisitions, venture capital, ipos, industry trends and investing. clients include investors (hedge funds, mutual funds and venture capitalists), biotech firms, big pharma, and technology transfer offices. selection of recent publications: - jeppsson, h. (2018). initial public offerings, subscription precommitments and venture capital participation. journal of corporate finance 50, 650-668. - jeppsson, h. (2018).